ID: ALA1683754

Max Phase: Preclinical

Molecular Formula: C28H33N9O8

Molecular Weight: 623.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(C)c2c(c(O)c1C/C=C(\C)CNCn1cc(OC[C@@H]3O[C@H](n4cnc5c(N)ncnc54)[C@@H](O)[C@H]3O)nn1)C(=O)OC2

Standard InChI:  InChI=1S/C28H33N9O8/c1-13(4-5-15-21(38)19-16(8-44-28(19)41)14(2)24(15)42-3)6-30-11-36-7-18(34-35-36)43-9-17-22(39)23(40)27(45-17)37-12-33-20-25(29)31-10-32-26(20)37/h4,7,10,12,17,22-23,27,30,38-40H,5-6,8-9,11H2,1-3H3,(H2,29,31,32)/b13-4+/t17-,22-,23-,27-/m0/s1

Standard InChI Key:  HKFKMRKJQZUMMG-OZXAFPNGSA-N

Associated Targets(Human)

Inosine-5'-monophosphate dehydrogenase 1 221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inosine-5'-monophosphate dehydrogenase 2 1326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 623.63Molecular Weight (Monoisotopic): 623.2452AlogP: 0.13#Rotatable Bonds: 11
Polar Surface Area: 227.04Molecular Species: NEUTRALHBA: 17HBD: 5
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.76CX Basic pKa: 7.20CX LogP: 1.83CX LogD: 1.61
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.11Np Likeness Score: 1.06

References

1. Felczak K, Chen L, Wilson D, Williams J, Vince R, Petrelli R, Jayaram HN, Kusumanchi P, Kumar M, Pankiewicz KW..  (2011)  Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.,  19  (5): [PMID:21324702] [10.1016/j.bmc.2011.01.042]

Source